{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreienxpvkjnkabitotjaotyoztjl6peeu7zkp62pal26o462gixcffu",
    "uri": "at://did:plc:eovmz6dbqbanxpynuzivgyc4/app.bsky.feed.post/3mngwvbbgnhy2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreicxkewyi2oas36vsutsemffjqye6zdgevqiczuzofpch5dkc2mjwu"
    },
    "mimeType": "image/jpeg",
    "size": 79557
  },
  "path": "/news/health/ovarian-cancer-nhs-treatment-mirvetuximab-soravtansine-b2988890.html",
  "publishedAt": "2026-06-04T05:39:17.000Z",
  "site": "https://www.the-independent.com",
  "tags": [
    "Health",
    "News"
  ],
  "textContent": "Experts have hailed the ‘landmark’ decision from the National Institute for Health and Care Excellence to approve the treatment for NHS use",
  "title": "First ovarian cancer treatment in decades given green light for NHS",
  "updatedAt": "2026-06-04T05:39:17.000Z"
}